ATLANTA - Emory Healthcare is taking the lead in preventive heart care by encouraging adults, particularly those with a family history of cardiovascular disease, to take a simple blood test that can determine their genetic risk for heart disease.
The one-time test measures a person’s level of Lipoprotein (a) or Lp(a), which is a type of lipid in the blood. An elevated level of Lipoprotein (a) puts a person at higher risk for heart attack, stroke and aortic valve disease. According to Emory Healthcare cardiologist Anurag Mehta, MD, less than 1% of adults get tested, but an astounding one in five adults has an elevated Lipoprotein(a) level.
“This simple blood test can be requested at a person’s appointment with their clinician and is also available as an on-demand direct to consumer test. It gives us important clues into their genetic risk and allows us to get ahead and start mitigating that risk,” says Mehta, who is also an assistant professor of medicine at Emory University School of Medicine.
“Although this is a genetic risk for heart disease, it does not mean that there is nothing you can do if you have elevated lp (a)” according to Ijeoma Isiadinso, MD, Associate Professor of Medicine and Director of Preventive Cardiology at Emory Healthcare. “In fact, this is where prevention can have a great impact and treating cardiovascular risk factors can help reduce your risk of developing heart disease”. Cardiologists at Emory are leading several clinical trials to better understand if lowering lp (a) can result in a lower risk of cardiovascular disease.
Dr. Isiadinso encourages discussing test results with family members. “In addition to knowing one’s risk, cascade screening which involves testing of first-degree relatives of those with elevated lp (a), can identify family members who are unknowingly at increased risk for heart disease and provides them an opportunity to lower their risk as well”. This is why it is so important to know one’s family history.
Lipoprotein (a) is similar in structure to LDL or low-density lipoprotein and contains another protein called apolipoprotein(a) that increases the chances of creating blood clots. But unlike LDL, genetics control it. “Lipoprotein (a) is a silent risk factor, and many will never know they have it without taking a blood test,” says Mehta.
Newsroom

Testing your Lipoprotein (a) can determine your genetic risk for heart disease.
Photo: Getty Images
Photo: Getty Images
“I’m grateful to know. I told all my friends to go and get tested."
A patient's story
Emory patient, Kelly Baranovic was encouraged to check her level of Lipoprotein (a) after her sister suggested they both take the test given their family history. Baranovic’s father died of a heart attack when she was a child. “I was there when my dad passed away and I’ve always thought, I don’t understand why he had to be taken away from me so young,” says Baranovic.
Having a child herself, there was no question she wanted to know her results. Baranovic has always considered herself a healthy, active person whose lab work looked normal at doctor’s visits. But recently, a test came back with elevated Lipoprotein (a) levels. “I was petrified, in shock really,” says Baranovic. “It just goes to show that you can be healthy and still be at risk.”
Baranovic is now being treated to mitigate her genetic risk through lifestyle modifications and cholesterol lowering medication. There is currently no FDA approved drug to directly treat elevated levels of Lipoprotein (a) but recent clinical trials, with several being conducted at Emory, are on a mission to change that.
“I’m grateful to know. I told all my friends to go and get tested,” says Baranovic.
Having a child herself, there was no question she wanted to know her results. Baranovic has always considered herself a healthy, active person whose lab work looked normal at doctor’s visits. But recently, a test came back with elevated Lipoprotein (a) levels. “I was petrified, in shock really,” says Baranovic. “It just goes to show that you can be healthy and still be at risk.”
Baranovic is now being treated to mitigate her genetic risk through lifestyle modifications and cholesterol lowering medication. There is currently no FDA approved drug to directly treat elevated levels of Lipoprotein (a) but recent clinical trials, with several being conducted at Emory, are on a mission to change that.
“I’m grateful to know. I told all my friends to go and get tested,” says Baranovic.

Kelly Baranovic decided to get tested for Lipoprotein (a) because of her family's history with heart disease.
Subscribe to our newsletter
Register to receive our newsletter, Emory Healthcare Pulse, and stay up-to-date on the latest news, events, information and more from Emory Healthcare. Subscribe Now
Related News
-
The Addiction Alliance of Georgia has opened a new 7,000-square-foot Adolescent Outpatient Program at the Emory Addiction Center in Atlanta, expanding access to specialized substance use prevention. -
Emory Healthcare remains a leading provider in ventricular assist device implantation for heart careEmory Healthcare has been named one of the nation’s leading providers in caring for patients who require a left ventricular assist device or LVAD implantation for the 5th year in a row. -
52-year-old patient, Monica is the first in Georgia to receive a HALT, heart-after-liver-transplant. This innovative procedure is giving patients in need of a new heart a second chance at life.
Media Contact
Audra Mincey
Emory Healthcare Heart & Vascular audra.mincey@emoryhealthcare.org
Emory Healthcare Heart & Vascular audra.mincey@emoryhealthcare.org
Resources
Recent News
-
Mar 20, 2026
-
Mar 3, 2026
-
Emory Healthcare remains a leading provider in ventricular assist device implantation for heart careFeb 24, 2026
-
Feb 16, 2026
Simple blood test can signal a silent genetic risk factor for heart disease, according to Emory cardiologists
Date: Mar 20, 2026
Print
Share
